BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 7293260)

  • 1. [The cardiovascular risk-profile of persons with normal, borderline disturbed and certain pathological glucose tolerance in dependence on the body-weight (author's transl)].
    Schneider H; Ziegelasch HJ
    Z Alternsforsch; 1981; 36(3):227-33. PubMed ID: 7293260
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Associated cardiovascular factors of risk in borderline-diabetes (author's transl)].
    Schneider H; Ziegelasch HJ
    Z Alternsforsch; 1980; 35(2):177-84. PubMed ID: 7456500
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The cardiovascular risk profile of the long-term diabetic].
    Schneider H; Pastow A
    Z Gesamte Inn Med; 1982 Feb; 37(4):125-8. PubMed ID: 7080561
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The cardiovascular risk profile in patients with disorders of glucose tolerance (borderline diabetes) dependent on the heredity of the diabetes].
    Schneider H; Ziegelasch HJ
    Z Gesamte Inn Med; 1981 Apr; 36(7):241-3. PubMed ID: 7281825
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The cardiovascular risk profile of subjects with normal, marginally disordered and proven pathological glucose tolerance].
    Schneider H; Burrmann H; Ziegelasch HJ
    Z Gesamte Inn Med; 1978 Feb; 33(4):110-2. PubMed ID: 645141
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The cardiovascular risk profile in persons with normal glucose tolerance with reference to the familial occurrence of diabetes mellitus].
    Schneider H; Ziegelasch HJ
    Z Gesamte Inn Med; 1981 May; 36(9):298-300. PubMed ID: 7306279
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Oral glucose tolerance tests--with or without estimation of serum insulin? (author's transl)].
    Haupt E; Petzoldt R; Probst S; Schöffling K
    Dtsch Med Wochenschr; 1981 Jun; 106(25):798-803. PubMed ID: 7016491
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Prevalence of newly diagnosed type 2 diabetes, impaired glucose tolerance and abnormal fasting glucose in a high risk population. Data from the RIAD study using new diagnostic criteria for diabetes].
    Köhler C; Temelkova-Kurktschiev T; Schaper F; Fücker K; Hanefeld M
    Dtsch Med Wochenschr; 1999 Sep; 124(37):1057-61. PubMed ID: 10520305
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Frequency of cardiovascular risk factors in renal transplant patients (author's transl)].
    Zazgornik J; Balcke P; Schmidt P; Kopsa H
    Wien Klin Wochenschr; 1978 Jun; 90(13):466-8. PubMed ID: 351973
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The cardiovascular risk profile of long-term diabetics and its relation to kidney function].
    Schneider H; Pastow A
    Z Gesamte Inn Med; 1982 May; 37(10):295-9. PubMed ID: 7102005
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The influence of diabetes heredity on cardiovasculary risk profile in patients with high age diabetes (author's transl)].
    Schneider H; Ziegelasch HJ
    Z Alternsforsch; 1981; 36(2):137-41. PubMed ID: 7303731
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Weight reduction and glucose intolerance in obese subjects (author's transl)].
    Berger M; Baumhoff E; Gries FA
    Dtsch Med Wochenschr; 1976 Feb; 101(9):307-11. PubMed ID: 1248416
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Importance of a number of risk factors and their combination in detecting diabetes with the prednisolone and glucose test].
    Baranov VG; Gasparian EG; Sitnikova AM; Konradi LI
    Probl Endokrinol (Mosk); 1986; 32(1):9-13. PubMed ID: 3952078
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Body fat mass distribution. Influence on metabolic and atherosclerotic parameters in non-insulin dependent diabetics and obese subjects with and without impaired glucose tolerance. Influence of weight reduction.
    Van Gaal L
    Verh K Acad Geneeskd Belg; 1989; 51(1):47-80. PubMed ID: 2800685
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of Nordic walking on cardiovascular risk factors in overweight individuals with type 2 diabetes, impaired or normal glucose tolerance.
    Fritz T; Caidahl K; Krook A; Lundström P; Mashili F; Osler M; Szekeres FL; Östenson CG; Wändell P; Zierath JR
    Diabetes Metab Res Rev; 2013 Jan; 29(1):25-32. PubMed ID: 22887834
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Glucose tolerance in the course of treating endogenous hypertriglyceridaemia (author's transl)].
    Vogelberg KH; Gries FA
    Dtsch Med Wochenschr; 1979 Jun; 104(22):808-14. PubMed ID: 456256
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Period prevalence of abnormal glucose tolerance and cardiovascular risk factors among obese children attending an obesity centre in Italy.
    Invitti C; Gilardini L; Pontiggia B; Morabito F; Mazzilli G; Viberti G
    Nutr Metab Cardiovasc Dis; 2006 May; 16(4):256-62. PubMed ID: 16679217
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Massive obesity with disturbance of glucose tolerance (author's transl)].
    Toeller M; Gries FA; Shleppinghoff B; Berger M; Dannehl K
    Dtsch Med Wochenschr; 1979 Oct; 104(43):1513-7. PubMed ID: 498973
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevalence of non-traditional cardiovascular disease risk factors among persons with impaired fasting glucose, impaired glucose tolerance, diabetes, and the metabolic syndrome: analysis of the Third National Health and Nutrition Examination Survey (NHANES III).
    Muntner P; He J; Chen J; Fonseca V; Whelton PK
    Ann Epidemiol; 2004 Oct; 14(9):686-95. PubMed ID: 15380800
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Bedford Survey: observations on retina and lens of subjects with impaired glucose tolerance and in controls with normal glucose tolerance.
    McCartney P; Keen H; Jarrett RJ
    Diabete Metab; 1983 Dec; 9(4):303-5. PubMed ID: 6667765
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.